Companies › COCP

Cocrystal Pharma Inc (COCP)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001412486 · EDGAR filings · Updated 2026-07-17

Cocrystal Pharma Inc (COCP) has reported institutional ownership of 5.6%, with 26 institutional managers holding positions valued at $783.8K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-17 — Current report (8-K) filed
• 2026-06-09 — Current report (8-K) filed
• 2026-06-03 — Insider transaction reported (Form 4)
• 2026-06-03 — Initial insider ownership filed (Form 3)
• 2026-06-03 — Current report (8-K) filed
• 2026-05-27 — DEFA14A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Cocrystal Pharma Inc has 26 institutional holders and institutional ownership of 5.6%.

Insider activity

Insiders reported 13 transactions (9 buys, 0 sells) across 4 reporting insiders, with a net reported value of $220.2K.

Data flags from SEC filings

Related companies

Phio Pharmaceuticals Corp (PHIO) · CELLECTAR BIOSCIENCES INC (CLRB) · ABVC BIOPHARMA INC (ABVC) · ERNEXA THERAPEUTICS INC (ERNA) · INTELLIGENT BIO SOLUTIONS IN (INBS) · GENENTA SCIENCE S P A (GNTA)